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The prevalence of head and neck cancer (HNC) survivors is on the rise. Treatments
for HNC can have a major deleterious impact on functions such as swallowing and
voice. Poor functional outcomes are strongly correlated with distress, low quality of
life, difficulties returning to work and socializing. Furthermore, dysphagia can have
serious medical consequences such as malnutrition, dehydration, and pneumonia.
A conservative estimate of the percentage of survivors living with dysphagia in the
long-term is between 50 and 60%. Evidence is emerging that functions can worsen
over time, sometimes several years following treatment due to radiation-associated
fibrosis, neuropathy, intractable edema, and atrophy. Muscles lose their strength,
pliability, stamina, and range, speed, precision, and initiation of movements necessary
for swallowing and voice functions. Late treatment effects can go unrecognized, and
may only be identified when there is a medical complication such as hospitalization for
aspiration pneumonia. In the routine healthcare setting methods of evaluation include
a detailed case history, a thorough clinical examination and instrumental assessments.
Interventions for late treatment effects are limited and it is imperative that patients at
risk are identified as early as possible. This paper considers the role of screening tests in
monitoring swallowing and detecting aspiration in the long-term. Further work is indicated
for addressing this pressing and increasingly common clinical problem.
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INTRODUCTION
The prevalence of head and neck cancer (HNC) survivors is on the increase, likely due
to improvements in diagnostic technologies, treatment techniques, and a rising number of
HPV-related oropharyngeal cancers, with patients presenting at a younger age with good survival
outcome (1). HNC treatments can result in a multitude of side effects resulting in poor
function. Post-treatment swallowing and voice difficulties are strongly related to psychosocial
problems, poorer quality of life, anxiety, and low mood (2, 3). In addition, dysphagia can pose a
serious medical threat, being associated with malnutrition, dehydration, and possibly pneumonia.
Survivors may therefore live for a long time with significant symptom burden, which can increase
in severity over time. This paper reports on the presentation, assessment, and potential screening
tests for late treatment effects on swallowing and voice.
Patterson Late Radiation Effects on Swallowing and Voice3
THE COMPLEXITY OF SWALLOWING AND
VOICE
Swallowing and voice are highly coordinated, specialized
functions involving over 25 pairs of muscles under both
voluntary and involuntary control. Swallowing is a finely tuned
process, primarily because the oropharynx is a shared passageway
for swallowing and respiration. It needs to be executed safely,
avoiding spillage into the airway, and efficiently, to ensure
adequate nourishment and hydration. Voice is produced by air
passing through the vocal folds, causing the edges to vibrate
rapidly. This sound is amplified by resonating cavities in the
vocal tract, giving it a distinctive quality. The active articulators
(tongue, lips and soft palate) modify the voiced sound into speech
via quick and precise movements.
LATE TREATMENT EFFECTS ON
FUNCTION
Surgical treatment for HNCmay result in functional impairment,
dependent on factors such as tumor site, volume resected,
reconstruction, and the subsequent level of edema, scarring,
and atrophy (4). Radiotherapy can create significant dysfunction
both acutely and progressively also termed “late effects.” Acute
radiotherapy side effects usually include pain, mucosititis, edema,
and xerostomia. For some, this results in mild or short-term
dysphagia and dysphonia, resolving by 3 months. This group are
likely to return to their normal diet with minor limitations. This
is a typical pattern for those treated by low dose radiotherapy
(2, 5), but may be achieved by a small percentage of patients with
advanced disease treated by intensity-modulated radiotherapy
(IMRT) (6).
DYSPHAGIA
Evidence relating to the long-term impact of treatment
on swallowing is emerging, with a number of potential
patterns described by Christianen (5). Some patients experience
progressive deterioration in the months and years following
treatment, whereas others may have a sudden onset of severe
dysphagia. Causes of these differing trajectories are not well-
understood. Chronic edema and increased fibroblast formation
are responsible for the overproduction of collagen, leading
to scarring, and fibrosis (7). Consequently, tissues lose their
elasticity and movements for adequate functioning are restricted.
Atrophy can alter oropharyngeal anatomical relationships and
reduce muscle strength. Furthermore, sensory impairment can
blunt the cough response, should food, or drink enter the airway.
Lower cranial nerve palsies (CN IX, X, and XII) have been
noted, probably due to compression or direct nerve damage
(8). Mandible osteoradionecrosis is a further late complication,
resulting in exposed, non-healing bone (9). This is strongly
associated with severe, chronic dysphagia (OR: 4.6, 95% CI:
2.1–10.3), making chewing painful and swallowing less efficient
(10). Dysphagia is strongly associated with psychological distress,
poorer quality of life, and is a top priority concern for HNC
survivors (2, 11, 12)
Prevalence of Late Effects Dysphagia
Little information is published on swallowing outcomes beyond
2 years. In our longitudinal study (n = 146 recruited pre-
treatment), aspiration rates remained stable between one and 6
years following chemoradiotherapy (22–25%), with one half of
these patients having silent aspiration (13). At 1 year, two patients
had a laryngectomy for a dysfunctional larynx and four had a
tracheostomy due to airway compromise. By 6 years, five further
patients had a laryngectomy for a dysfunctional larynx (13). An
Australian study reported a decline in swallowing efficiency over
the same time frame (14). The RTOG 91–11 5 year follow up
identified severe dysphagia in a third of the retained sample (15).
SEER data reported a 49% rate of persistent dysphagia (16, 17),
with older patients following non-surgical treatment being most
at risk (18, 19).
Dysphagia Associated Risk
Aspiration is a medical concern as it can lead to repeated
chest infections, poor pulmonary function, and life-threatening
aspiration pneumonia (20). In our 6 year follow up cohort, 28%
reported at least one chest infection, with an increased risk ratio
of 6.25 [p = 0.03 CI 1.1–35.7] for aspirators (13). Seven percent
of those initially diagnosed with oropharyngeal cancer had a non-
functioning larynx, requiring complex, and major reconstructive
surgery (13). SEER data suggests the incidence of aspiration
pneumonia in HNC is 8.7% (95% CI: 8.2–9.1) (17) and it is
estimated that over 80% require hospital admission, half of whom
transfer to intensive care (20). Case series and cross-sectional
data report alarmingly high rates of aspiration-related deaths
(21–23). For example, the 30-day mortality rate in a series of
nasopharyngeal cancer patients was 51% (24). It is crucial that
we identify those at risk of developing aspiration pneumonia as
early as possible.
DYSPHONIA
The prevalence of late voice problems are not well-documented.
Small studies suggest deterioration in patient reports and clinical
tests of voice up to 7 years post-treatment (25, 26). However,
patients treated with IMRT appear to have better outcomes than
those treated with conventional radiotherapy, in the long-term
(3). A small percentage of patients may require a tracheostomy
or laryngectomy, significantly altering voice quality (13).
ASSESSMENT
Clinical Swallowing and Voice Assessment
In the first instance, patients presenting with new symptoms,
or deterioration in function should have recurrent or primary
disease excluded as a possible cause. A comprehensive clinical
history of late effects will include details on patients’ perceptions
of the onset, trajectory, and symptoms. Clinical information
such as co-morbidities, reflux, chest status, oral intake, oral
hygiene, and weight should be gathered. For older survivors,
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expected, age-related functional decline i.e., loss of muscle mass
and elasticity, reduced saliva production should be taken into
account. An examination will typically include and oral and
oromotor assessment, palpation of laryngeal structures, voice,
and speech quality assessment and an observation of eating
and drinking.
There are no agreed standards for long-term voice assessment,
although review papers call for structured, standardized
protocols, with measurements taken at baseline and long-
term (27, 28). These typically include clinician rated scales,
intelligibility rating, and acoustic measures (29). Examples of
scales and measures used in HNC are given in Table 1.
Patient Reported Outcome Measures
Measures of function in HNC should include patient-
reported outcomes both pre- and post-treatment. Swallowing
questionnaires and symptom report tools capture patients’
perspectives of dysphagia, but they are only weakly correlated
with swallowing impairment and aspiration, the relationship
being particularly poor beyond 12 months post-treatment.
They are therefore not interchangeable with clinical
assessment (36, 37). The most commonly reported swallowing
questionnaires used in HNC care include M.D. Anderson
Dysphagia Inventory (38), SWAL-QOL (39), Sydney Swallow
Questionnaire (40), and the EAT-10 (41). Examples of patient
reported voice questionnaires include Voice Handicap Index
(30), Voice Symptom Scale (32), and the Vocal Performance
Questionnaire (42).
Instrumental Assessment
Instrumental examination(s) is indicated for a thorough
investigation of pathophysiology. Videofluoroscopy (VF) and
TABLE 1 | Examples of voice outcome measures used in HNC.
Voice measures Description
Patient reported measures Voice handicap index VHI-10 (30). 10 items on 5
point scale
Voice-related quality of life V-RQOL (31). 10 items, 5
point scale and an overall score
Voice symptom scale VoiSS (32). 30 items 3
subscales impairment-related, emotional, and
physical symptoms
Vocal performance questionnaire VPQ (33). 12
items, 5 point ordinal scale
Clinician rated measures GRBAS (34) roughness, breathiness, asthenia,
strain. 4 point scale for each area and overall grade
Consensus Auditory-Perceptual Evaluation of Voice
(CAPE V) (35). Overall severity, roughness,
breathiness, strain, pitch, loudness. 6 vocal
attributes measured on a visual analog scale
Acoustic and aerodynamic
measures
Fundamental frequency-vocal fold vibration
frequency
Pertubation-Jitter: irregularities in vocal fold
frequency, Shimmer: amplitude irregularities.
Harmonic to noise ratio-ratio of sound frequencies
to noise energy in the voice
Maximum phonation time-glottic efficiency
Fiberoptic Endoscopic Evaluation of Swallowing (FEES R©) are the
most commonly used instrumental swallow assessments (43). VF
is a recorded radiographic study of the swallowing structures,
their movement and co-ordination. It is usually conducted in the
lateral and anterior-posterior plane. Test boluses are mixed with
radio-opaque material to enable visualization. FEES R© allows a
direct view of nasolaryngopharyngeal anatomy and physiology
followed by an assessment of swallowing function (44, 45). A
range of fluid and food can be given, without requiring radio
opaque contrast. This may be combined with a voice assessment,
which also requires a stroboscopic light source to fully assess
vocal fold function and mucosal wave pattern.
The presentation of late treatment effects on instrumental
assessment constitutes a number of features such as;
• Excessive external lymphedema, with underlying
tissue hardening.
• Internal edema in critical structures and spaces for functioning
e.g., true vocal folds, epiglottis, pyriform sinuses.
• Thickening of structures e.g., pharyngo-epiglottic folds
creating a shelf-like barrier to bolus flow.
• Muscle thinning e.g., atrophied tongue base and
pharyngeal wall.
• Palsies of the tongue, vocal fold, soft palate.
• Excessively dry laryngopharyngeal muscosa.
The pathophysiology, safety, and efficiency of swallowing can be
analyzed and measured using rating scales, a selection of which
are presented in Table 2.
MONITORING
Cancer surveillance reviews are usually offered up to 5 years
following treatment (1). Swallowing and voice function may
TABLE 2 | Examples of swallowing rating scales for FEES® and VF.
Rating scale Assessment
FEES VF
Penetration Aspiration Scale (49)
8-point scale describing laryngeal penetration and
aspiration and sensory response
Yes Yes
The MBS Impairment Scale (50)
16-item scale of swallow physiology and residue
No Yes
Dynamic Image Grade of Swallowing Toxicity
(DIGEST) (51)
Summary score for swallow safety and efficiency
No Yes
Oropharyngeal swallow efficiency (52)
Combined measure of residue and aspiration
No Yes
Patterson’s Oedema Scale (53)
4-point scale of laryngopharyngeal structures and
spaces
Yes No
The Boston Residue and Clearance Scale (54)
11-point scale scoring amount, location and
clearance of residue
Yes No
Yale Pharyngeal Residue Severity Rating Scale (55),
5-point scale on amount of pharyngeal residue
Yes No
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not be routinely tested, unless patients report a problem. One
preliminary study proposes four questions that could be used
as part of a clinical assessment to detect dysphagia i.e., Do you
have difficulties: (1) drinking? (2) eating? (3) swallowing? (4)
Do you cough when eating/drinking? When three or more of
these questions were answered affirmatory, the likelihood of
aspiration observed on VF increased (46). Given afore described
mortality risks, and the preponderance of sub-clinical aspiration,
the immediate clinical challenge is identifying those at risk
of developing pneumonia, using reliable, repeatable, and cost-
effective tests.
Identifying Patients at Risk of Aspiration
Pneumonia
Healthy adults can experience trace aspiration without
adverse consequences, and not every HNC survivor with
aspiration appears to develop pneumonia. In a series of partial
laryngectomy patients, 65% were identified with aspiration,
but without x-ray evidence of pneumonia or infection (47).
There may be additional factors to be taken into account,
when weighing up pneumonia risk. For example, older
adults in a care facility developed pneumonia only when
aspiration co-occurred with poor oral hygiene, dependence
on others for eating, poor dentition and co-morbidities
(48). Most HNC studies have explored patient and disease
characteristics and treatment type as predictors of pneumonia,
with no clear pattern emerging (see Table 3). Further work
on identifying predictor variables for aspiration pneumonia
to be used as part of an algorithm for monitoring purposes
is required.
Screening Assessments
Instrumental assessments provide a more objective way of
measuring swallowing, but have limited access and high cost,
due to the need for specialist equipment and personnel (56). In
Stroke care, early detection of dysphagia by screening reduces
pulmonary complications, length of hospital stay, and overall
health care costs (57). No such programme exists for HNC
survivors, but the following section reviews candidate screening
tests for this group.
Water Swallow Test
A water swallow test (WST) is the most commonly reported
aspiration screening tool (58). Two systematic reviews report
a range of protocols, predominantly for testing neurological
dysphagia (56, 58–61). Using prescribed amounts of water and
recording coughing or a wet voice gave the most accurate
results for identifying aspiration (56, 62). Consecutive sips
with large volumes had the best sensitivity (91% CI 89,
93%) while, single sips of water were better at ruling out
aspiration (90% CI 86, 93%) (58). We have reported on
the timed 100 mLs WST in HNC, recording swallowing
performance overtime, as well as a screening test for aspiration
(63). This test was acceptable for identifying aspiration in
early post-operative or chemoradiotherapy patient groups
(63, 64), but its reliability for late effects patients has not
been investigated.
Cough Reflex Test
This test assesses the cough reflex by introducing a tussive agent
such as citric acid via a facemask and nebulizer and observing
for a responsive cough (65). The outcome is judged on reflexive
cough strength and has been used as screening test in Stroke (65),
Parkinson’s Disease (66), and post-extubation (67). The absence
of a cough reflex in neurological patients has a sensitivity of 69%
(95% CI 55, 81%) and specificity of 71% (95% CI 63, 77%) to
detect aspiration (65). No studies have reported on its use in
HNC, but given that late effects can result in silent aspiration,
further investigation is warranted.
Pulmonary Function
Many patients elect to eat and drink despite experiencing
aspiration. Assessments to monitor pulmonary function
such as spirometry and flow-volume loops may be
TABLE 3 | HNC studies reporting predictors of (1) aspiration pneumonia* (2) aspiration pneumonia-related death** 6= Wang et al. (24) only included patients with a
diagnosis of aspiration pneumonia.
Author N T site Tx % AP Predictors of AP Non-predictive
Hunter et al. (69) 72 OPSCC C-IMRT 22% T-stage, patient report, aspiration on
VF*
CTCAE
Xu et al. (20) 3513 Mixed Surgery and RT, CRT, RT 16% 1Y 24% 5Y Hypopharynx or NPC, gender, age,
co-morbidity, primary RT, care at
non-teaching hospital*
Surgery, stage, type of CT, type
of RT
Kawai et al. (70) 305 Mixed CRT 21% Alcohol, sleeping pills, oral hygiene,
hypoalbumemia, presence of other
cancer*
Madan et al. (71) 85 Mixed Surgery & RT, CRT, RT 60% Pharynx cancer, T stage** Age, gender, tx modality,
smoking, co-morbidity, treatment
intent, baseline swallowing
Wang et al. (24) 113 NPC RT +/– CT IMRT 100% 6= age, smoking, weight loss, lower CN
palsy**
O’Hare et al. (72) 206 Mixed RT +/– CT 15% Larynx cancer, dose to cricopharynx** Gender, chemotherapy
NPC, nasopharynx cancer; OPSCC, oropharynx cancer; T, tumor; Tx, treatment; CRT, chemoradiotherapy; RT, radiotherapy; CT, chemotherapy.
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indicated together with close collaboration with Respiratory
Physicians to develop mechanisms to detect deterioration in
chest status.
FUTURE DIRECTIONS
There are a number of current trials investigating treatment
modulation to prevent or reduce toxicities without
compromising survival (68). In the meantime, further work on
late functional effects is indicated in the following areas.
• Information on the long-term outcomes for voice and speech.
• Identification of predictors of significant fibrosis and
exploration of preventative interventions.
• Identification of predictor variables for pneumonia in patients
who aspirate.
• Reliable screening tests for identifying aspiration and
dysphagia for long-term follow up.
• Accurate patient information regarding late treatment effects.
• Clinical care pathways for identifying and monitoring late
functional effects.
CONCLUSION
The number of HNC survivors is rising and this trend
is set to continue. Late functional effects of treatment is
a common, distressing, and potentially life-threatening
problem. Assessment and monitoring of HNC survivors
in the long-term is an important step for identifying
those at risk, as early as possible. Reliable, acceptable, and
repeatable screening assessments are needed to address this
growing problem.
AUTHOR CONTRIBUTIONS
The author confirms being the sole contributor of this work and
has approved it for publication.
REFERENCES
1. Nguyen NTA, Ringash J. Head and neck cancer survivorship care: a review of
the current guidelines and remaining unmet needs. Curr Treat Options Oncol.
(2018) 19:44. doi: 10.1007/s11864-018-0554-9
2. Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head and
neck cancer treatment: patients’ perspectives. Otolaryngol Head Neck Surg.
(2011) 145:767–71. doi: 10.1177/0194599811414506
3. Kraaijenga SAC, Oskam IM, van Son RJ, Hamming-Vrieze O, Hilgers
FJ, van den Brekel MW, van der Molen L. Assessment of voice,
speech, and related quality of life in advanced head and neck cancer
patients 10-years+ after chemoradiotherapy. Oral Oncol. (2016) 55:24–30.
doi: 10.1016/j.oraloncology.2016.02.001
4. Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE,
et al. Swallowing dysfunction–preventative and rehabilitation strategies in
patients with head-and-neck cancers treated with surgery, radiotherapy, and
chemotherapy: a critical review. Int J Radiation Oncol Biol Phys. (2003)
57:1219–30. doi: 10.1016/S0360-3016(03)01454-8
5. Christianen MEMC, Verdonck-de Leeuw IM, Doornaert P, Chouvalova
O, Steenbakkers RJ, Koken PW, et al. Patterns of long-term swallowing
dysfunction after definitive radiotherapy or chemoradiation. Radiother Oncol.
(2015) 117:139–44. doi: 10.1016/j.radonc.2015.07.042
6. Roe JWG, Carding PN, Drinnan MJ, Harrington KJ, Nutting CM, et al.
Swallowing performance and tube feeding status in patients treated with
parotid-sparing intensity-modulated radiotherapy for head and neck cancer.
Head Neck. (2016) 38:E1436–44. doi: 10.1002/hed.24255
7. Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM.
Radiation-induced fibrosis: mechanisms and implications for therapy. J
Cancer Res Clin Oncol. (2015) 141:1985–94. doi: 10.1007/s00432-015-1974-6
8. Rison RA, Beydoun SR. Delayed cervicobulbar neuronopathy and
myokymia after head and neck radiotherapy for nasopharyngeal
carcinoma: a case report. J Clin Neuromuscul Dis. (2011) 12:147–52.
doi: 10.1097/CND.0b013e31820d4f20
9. Strojan P, Hutcheson KA, Eisbruch A, Beitler JJ, Langendijk JA, Lee AWM,
et al. Treatment of late sequelae after radiotherapy for head and neck cancer.
Cancer Treat Rev. (2017) 59:79–92. doi: 10.1016/j.ctrv.2017.07.003
10. Wong ATT, et al. Symptom burden and dysphagia associated with
osteoradionecrosis in long-term oropharynx cancer survivors: a cohort
analysis.Oral Oncol. (2017) 66:75–80. doi: 10.1016/j.oraloncology.2017.01.006
11. Rhoten BA, et al. Depressive symptoms, social anxiety, and perceived neck
function in patients with head and neck cancer. Head and Neck. (2018)
40:1443-1452. doi: 10.1002/hed.25129
12. Patterson JM, McColl E, Carding PN, Hildreth AJ, Kelly C, Wilson JA.
Swallowing in the first year after chemoradiotherapy for head and neck
cancer: clinician-and patient-reported outcomes. Head Neck. (2014) 36,
352–8. doi: 10.1002/hed.23306
13. Patterson JM, McColl E, Carding PN, Wilson JA. Swallowing beyond six years
post (chemo)radiotherapy for head and neck cancer; a cohort study. Oral
Oncol. (2018) 83:53–8. doi: 10.1016/j.oraloncology.2018.06.003
14. Frowen J, Drosdowsky A, Perry A, Corry J. Long-term swallowing after
chemoradiotherapy: prospective study of functional and patient-reported
changes over time. Head Neck. (2016) 38:E307–15. doi: 10.1002/hed.23991
15. Ward MC, Adelstein DJ, Bhateja P, Nwizu TI, Scharpf J, Houston N, et al.
Severe late dysphagia and cause of death after concurrent chemoradiation for
larynx cancer in patients eligible for RTOG 91-11.Oral Oncol. (2016) 57:21–6.
doi: 10.1016/j.oraloncology.2016.03.014
16. Shune SE, Karnell LH, Karnell MP, Van Daele DJ, Funk GF. Association
between severity of dysphagia and survival in patients with head and
neck cancer. Head Neck-J Sci Special Head Neck. (2012) 34:776–84.
doi: 10.1002/hed.21819
17. Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK,
et al. Two-year prevalence of dysphagia and related outcomes in head and
neck cancer survivors: an updated SEER-Medicare analysis.HeadNeck. (2019)
41:479–87. doi: 10.1002/hed.25412
18. Gourin CG, Starmer HM, Herbert RJ, Frick KD, Forastiere AA, Quon H, et al.
Quality of care and short- and long-term outcomes of laryngeal cancer care in
the elderly. Laryngoscope. (2015) 125:2323–9. doi: 10.1002/lary.25378
19. Motz K, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Eisele DW, et al.
Short- and long-term outcomes of oropharyngeal cancer care in the elderly.
Laryngoscope. (2018) 128:2084–93. doi: 10.1002/lary.27153
20. Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, et al. Aspiration
pneumonia after concurrent chemoradiotherapy for head and neck cancer.
Cancer. (2015) 121:1303–11. doi: 10.1002/cncr.29207
21. Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MW, et al.
Late dysphagia after radiotherapy-based treatment of head and neck cancer.
Cancer. (2012) 118:5793–9. doi: 10.1002/cncr.27631
22. Szczesniak MM, Maclean J, Zhang T, Graham PH, Cook IJ. Persistent
dysphagia after head and neck radiotherapy: a common and under-reported
complication with significant effect on non-cancer-related mortality. Clin
Oncol. (2014) 26:697–703. doi: 10.1016/j.clon.2014.08.009
23. Dong Y, Ridge JA, Li T, Lango MN, Churilla TM, Bauman JR,
et al. Long-term toxicities in 10-year survivors of radiation treatment
for head and neck cancer. Oral Oncol. (2017) 71(Suppl C):122–8.
doi: 10.1016/j.oraloncology.2017.05.009
Frontiers in Oncology | www.frontiersin.org 5 May 2019 | Volume 9 | Article 401
Patterson Late Radiation Effects on Swallowing and Voice3
24. Wang JJ, Jiang RS, Yen TT, Liang KL. Risk factors for recurrent pneumonia
in post-irradiated patients with nasopharyngeal carcinoma. J Chin Med Assoc.
(2017) 80:558–62. doi: 10.1016/j.jcma.2017.01.006
25. Davies-Husband C, Murphy J, Kelly C, Drinnan M, Paleri V. Extreme long-
term voice outcomes after concurrent chemoradiotherapy for advanced non-
laryngeal head and neck cancer: eight-year post-treatment analysis. Clin
Otolaryngol. (2018) 43:1494–9. doi: 10.1111/coa.13204
26. Dwivedi RC, St Rose S, Chisholm EJ, Clarke PM, Kerawala CJ, Nutting CM,
et al. Acoustic parameters of speech: lack of correlation with perceptual
and questionnaire-based speech evaluation in patients with oral and
oropharyngeal cancer treated with primary surgery. Head Neck. (2016)
38:670–6. doi: 10.1002/hed.23956
27. Jacobi I, van der Molen L, Huiskens H, van Rossum MA, Hilgers FJ. Voice
and speech outcomes of chemoradiation for advanced head and neck cancer:
a systematic review. Eur Arch Oto-Rhino-Laryngol. (2010) 267:1495–505.
doi: 10.1007/s00405-010-1316-x
28. Schuster M, Stelzle F. Outcome measurements after oral cancer treatment:
speech and speech-related aspects-an overview. Oral Maxillofacial Surg.
(2012) 16:291–8. doi: 10.1007/s10006-012-0340-y
29. Dwivedi RC, Kazi RA, Agrawal N, Nutting CM, Clarke PM, Kerawala CJ, et al.
Evaluation of speech outcomes following treatment of oral and oropharyngeal
cancers. Cancer Treat Rev. (2009) 35:417–24. doi: 10.1016/j.ctrv.2009.04.013
30. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and
validation of the voice handicap index-10. Laryngoscope. (2004) 114:1549–56.
doi: 10.1097/00005537-200409000-00009
31. Hogikyan ND, Sethuraman G, Validation of an instrument to measure
voice-related quality of life (V-RQOL). J Voice. (1999) 13:557–69.
doi: 10.1016/S0892-1997(99)80010-1
32. Deary IJ, Wilson JA, Carding PN, MacKenzie K. VoiSS: a patient-
derived voice symptom scale. J Psychosomat Res. (2003) 54:483–489.
doi: 10.1016/S0022-3999(02)00469-5
33. Carding PN, Horsley IA. An evaluation study of voice therapy in
non-organic dysphonia. Int J Lang Commun Disord. (1992) 27:137–58.
doi: 10.3109/13682829209012036
34. Hirano M, Clinical Examination of Voice. 1981. New York, NY: Springer.
35. Association, A.S.a.H. Consensus Auditory-Perceptual Evaluation of Voice
(CAPE-V). (2002) Available online at: https://www.asha.org/uploadedFiles/
members/divs/D3CAPEVprocedures.pdf.
36. Pedersen A, Wilson J, McColl E, Carding P, Patterson J. Swallowing outcome
measures in head and neck cancer - How do they compare?Oral Oncol. (2016)
52:104–8. doi: 10.1016/j.oraloncology.2015.10.015
37. Arrese LC, Carrau R, Plowman EK. Relationship between the eating
assessment Tool-10 and objective clinical ratings of swallowing function
in individuals with head and neck cancer. Dysphagia. (2017) 32:83–9.
doi: 10.1007/s00455-016-9741-7
38. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J,
et al. The development and validation of a dysphagia-specific quality-
of-life questionnaire for patients with head and neck cancer: the M.
D. Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg.
(2001) 127:870–6. doi: 10.1001/pubs.Arch Otolaryngol.Head Neck
Surg.-ISSN-0886-4470-127-7-ooa00162
39. McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE,
et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal
dysphagia in adults: III. Documentation of reliability and validity. Dysphagia.
(2002) 17:97–114. doi: 10.1007/s00455-001-0109-1
40. Wallace KL, Middleton S, Cook IJ. Development and validation of a self-
report symptom inventory to assess the severity of oral-pharyngeal dysphagia.
Gastroenterology. (2000) 118:678–87. doi: 10.1016/S0016-5085(00)70137-5
41. Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, et al.
Validity and reliability of the eating assessment tool (EAT-10).AnnOtol Rhinol
Laryngol. (2008) 117:919–24. doi: 10.1177/000348940811701210
42. Carding PN, Horsley IA, Docherty GJ. A study of the effectiveness of voice
therapy in the treatment of 45 patients with nonorganic dysphonia. J Voice.
(1999) 13:72–104. doi: 10.1016/S0892-1997(99)80063-0
43. Goldsmith T, Jacobson MC. Managing the late effects of chemoradiation on
swallowing: bolstering the beginning, minding the middle, and cocreating
the end. Curr Opin Otolaryngol Head Neck Surg. (2018) 26:180–7.
doi: 10.1097/MOO.0000000000000455
44. RCSLT. Fibreoptic Endoscopic Evaluation of Swallowing (FEES): The Role of
Speech and Language Therapy Royal College of Speech and Language Therapists
Position Paper. London: RCSLT (2015). Available online at: https://www.rcslt.
org/-/media/Project/RCSLT/fees-position-paper-march-2015.pdf.
45. Langmore SE. Endoscopic Evaluation and Treatment of Swallowing Disorders.
New York, NY: Thieme. (2001).
46. Hedström J, Tuomi L, Finizia C, Olsson C. Correlations between patient-
reported dysphagia screening and penetration-aspiration scores in head
and neck cancer patients post-oncological treatment. Dysphagia. (2018)
33:206–15. doi: 10.1007/s00455-017-9847-6
47. Simonelli M, Ruoppolo G, de Vincentiis M, Di Mario M, Calcagno P,
Vitiello C, et al. Swallowing ability and chronic aspiration after supracricoid
partial laryngectomy. Otolaryngol Head Neck Surg. (2010) 142:873–8.
doi: 10.1016/j.otohns.2010.01.035
48. Langmore SE, Terpenning MS, Schork A, Chen Y, Murray JT, Lopatin D, et al.
Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia.
(1998) 13:69–81. doi: 10.1007/PL00009559
49. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-
aspiration scale. Dysphagia. (1996) 11:93–8. doi: 10.1007/BF00417897
50. Martin-Harris B, Brodsky MB, Michel Y, Castell DO, Schleicher M, Sandidge
J, et al. MBSmeasurement tool for swallow impairment-MBSimp: establishing
a standard. Dysphagia. (2008) 23:392–405. doi: 10.1007/s00455-008-9185-9
51. Hutcheson KA, Barrow MP, Barringer DA, Knott JK, Lin HY, Weber RS, et al.
Dynamic imaging grade of swallowing toxicity (DIGEST): scale development
and validation. Cancer. (2017) 123:62–70. doi: 10.1002/cncr.30283
52. Rademaker AW, Pauloski BR, Logemann JA, Shanahan TK. Oropharyngeal
swallow efficiency as a representative measure of swallowing function. J Speech
Hear Res. (1994) 37:314–25. doi: 10.1044/jshr.3702.314
53. Patterson JM, Hildreth A, Wilson JA. Measuring edema in irradiated head
and neck cancer patients. Ann Otol Rhinol Laryngol. (2007) 116:559–64.
doi: 10.1177/000348940711600801
54. Kaneoka AS, Langmore SE, Krisciunas GP, Field K, Scheel R, McNally E, et al.
The Boston residue and clearance scale: preliminary reliability and validity
testing. Folia Phoniatr et Logopaed. (2014) 65:312–7. doi: 10.1159/0003
65006
55. Neubauer PD, Rademaker AW, Leder S B. The yale pharyngeal residue
severity rating scale: an anatomically defined and image-based tool.
Dysphagia. (2015) 30:521–8. doi: 10.1007/s00455-015-9631-4
56. Bours GJ, Speyer R, Lemmens J, Limburg M, de Wit R. Bedside
screening tests vs. videofluoroscopy or fibreoptic endoscopic evaluation
of swallowing to detect dysphagia in patients with neurological
disorders: systematic review. J Adv Nurs. (2009) 65:477–93. doi: 10.1111/
j.1365-2648.2008.04915.x
57. Marsh K, Bertranou E, Suominen H, Venkatachalam M. The Economic
Case for Speech And Language Therapy. Report Matrix Evidence (2010).
Available online at: https://optimityadvisors.com/sites/default/files/research-
papers/45-Speech-and-Language.pdf
58. Brodsky MB, Suiter DM, González-Fernández M, Michtalik HJ, Frymark
TB, Venediktov R, et al. Screening accuracy for aspiration using bedside
water swallow tests: a systematic review and meta-analysis. Chest. (2016)
150:148–63. doi: 10.1016/j.chest.2016.03.059
59. Jiang JL, Fu SY, Wang WH, Ma YC. Validity and reliability of swallowing
screening tools used by nurses for dysphagia: a systematic review. Tzu Chi
Med J. (2016) 28:41–8. doi: 10.1016/j.tcmj.2016.04.006
60. Chen PC, Chuang CH, Leong CP, Guo SE, Hsin YJ. Systematic review
and meta-analysis of the diagnostic accuracy of the water swallow test
for screening aspiration in stroke patients. J Adv Nurs. (2016) 72:2575–86.
doi: 10.1111/jan.13013
61. Virvidaki IE, Nasios G, KosmidouM,Giannopoulos S,Milionis H. Swallowing
and aspiration risk: a critical review of non instrumental bedside screening
tests. J Clin Neurol. (2018) 14:265–74. doi: 10.3988/jcn.2018.14.3.265
62. McCullough GH, Rosenbek JC, Wertz RT, McCoy S, Mann G, McCullough
K. Utility of clinical swallowing examination measures for detecting
aspiration post-stroke. J Speech Language Hear Res. (2005) 48:1280–93.
doi: 10.1044/1092-4388(2005/089)
63. Patterson JM, McColl E, Carding PN, Kelly C, Wilson JA. Swallowing
performance in patients with head and neck cancer: a simple clinical test.Oral
Oncol. (2009) 45:904–7. doi: 10.1016/j.oraloncology.2009.03.012
Frontiers in Oncology | www.frontiersin.org 6 May 2019 | Volume 9 | Article 401
Patterson Late Radiation Effects on Swallowing and Voice3
64. Hey C, Lange BP, Eberle S, Zaretsky Y, Sader R, Stöver T, et al. Water
swallow screening test for patients after surgery for head and neck
cancer: early identification of dysphagia, aspiration and limitations of
oral intake. Anticancer Res. (2013) 33:4017–22. doi: 10.1007/s00455-014-
9536-7
65. Miles A, Moore S, McFarlane M, Lee F, Allen J, Huckabee ML.
Comparison of cough reflex test against instrumental assessment of
aspiration. Physiol Behav. (2013) 118:25–31. doi: 10.1016/j.physbeh.2013.
05.004
66. Troche MS, Schumann B, Brandimore AE, Okun MS, Hegland
KW. Reflex cough and disease duration as predictors of swallowing
dysfunction in parkinson’s disease. Dysphagia. (2016) 31:757–64.
doi: 10.1007/s00455-016-9734-6
67. Kallesen M, Psirides A, Huckabee ML. Comparison of cough reflex testing
with videoendoscopy in recently extubated intensive care unit patients. J Crit
Care. (2016) 33:90–4. doi: 10.1016/j.jcrc.2016.02.004
68. Patterson JM, Brady GC, JRoe WG. Research into the prevention
and rehabilitation of dysphagia in head and neck cancer: a UK
perspective. Curr Opin Otolaryngol Head Neck Surg. (2016) 24:208–14.
doi: 10.1097/MOO.0000000000000260
69. Hunter KU, Lee OE, Lyden TH, Haxer MJ, Feng FY, Schipper M, et al.
Aspiration pneumonia after chemo-intensity-modulated radiation therapy of
oropharyngeal carcinoma and its clinical and dysphagia-related predictors.
Head Neck. (2014) 36:120–5. doi: 10.1002/hed.23275
70. Kawai S, Yokota T, Onozawa Y, Hamauchi S, Fukutomi A, OgawaH, et al. Risk
factors for aspiration pneumonia after definitive chemoradiotherapy or bio-
radiotherapy for locally advanced head and neck cancer: a monocentric case
control study. BMC Cancer. (2017) 17:59. doi: 10.1186/s12885-017-3052-8
71. Madan R, Kairo AK, Sharma A, Roy S, Singh S, Singh L, et al.
Aspiration pneumonia related deaths in head and neck cancer patients:
a retrospective analysis of risk factors from a tertiary care centre
in North India. J Laryngol Otol. (2015) 129:710–4. doi: 10.1017/
S0022215115001450
72. O’Hare J, Maclean J, Szczesniak M, Gupta R, Wu P, Quon H, et al.
Laryngeal tumours and radiotherapy dose to the cricopharyngeus are
predictive of death from aspiration pneumonia. Oral Oncol. (2017) 64:9–14.
doi: 10.1016/j.oraloncology.2016.11.010
Conflict of Interest Statement: The author declares that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Patterson. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Oncology | www.frontiersin.org 7 May 2019 | Volume 9 | Article 401
